varegacestat
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2024 (NCT06677996)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06855264 | Phase 1 | May 31, 2025 | Immunome, Inc. |
| NCT06841315 | Phase 1 | Mar 7, 2025 | Immunome, Inc. |
| NCT06845852 | Phase 1 | Feb 28, 2025 | Immunome, Inc. |
| NCT06677996 | Phase 1 | Nov 30, 2024 | Celerion, Immunome, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immunome, Inc. | For profit | 4 | 4 | 1 | 2024 |
| Celerion | For profit | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1